Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ratain

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Hairy cell leukaemia: the role of alpha interferonL C Platanias, M J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Clinical trial designs for cytostatic agentsM J Ratain, W M Stadler
Cancer Treatment Reports|October 1, 1987
Limited sampling model for vinblastine pharmacokineticsM J Ratain, N J Vogelzang
Oncology (Williston Park, N.Y.)|February 12, 1998
Rationale for phase I study of UFT plus leucovorin and oral JM-216M D DeMario, M J Ratain
Annals of Internal Medicine|August 1, 1985
Cancer chemotherapy and skin changesN J Vogelzang, M J Ratain
Investigational New Drugs|June 1, 2000
Development of target-based antineoplastic agentsW M Stadler, M J Ratain
Clinical Pharmacology and Therapeutics|August 31, 2007
Rapamycin: something old, something new, sometimes borrowed and now renewedC M Hartford, M J Ratain
Nature Medicine|March 7, 2001
Gazing into a crystal ball-cancer therapy in the post-genomic eraM J Ratain, M V Relling
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Pharmacogenetics in cancer etiology and chemotherapyA V Boddy, M J Ratain
Cancer Research|September 1, 1986
Phase I and pharmacological study of vinblastine by prolonged continuous infusionM J Ratain, N J Vogelzang
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Hairy cell leukaemia: the role of alpha interferonL C Platanias, M J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Clinical trial designs for cytostatic agentsM J Ratain, W M Stadler
Cancer Treatment Reports|October 1, 1987
Limited sampling model for vinblastine pharmacokineticsM J Ratain, N J Vogelzang
Oncology (Williston Park, N.Y.)|February 12, 1998
Rationale for phase I study of UFT plus leucovorin and oral JM-216M D DeMario, M J Ratain
Annals of Internal Medicine|August 1, 1985
Cancer chemotherapy and skin changesN J Vogelzang, M J Ratain
Investigational New Drugs|June 1, 2000
Development of target-based antineoplastic agentsW M Stadler, M J Ratain
Clinical Pharmacology and Therapeutics|August 31, 2007
Rapamycin: something old, something new, sometimes borrowed and now renewedC M Hartford, M J Ratain
Nature Medicine|March 7, 2001
Gazing into a crystal ball-cancer therapy in the post-genomic eraM J Ratain, M V Relling
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Pharmacogenetics in cancer etiology and chemotherapyA V Boddy, M J Ratain
Cancer Research|September 1, 1986
Phase I and pharmacological study of vinblastine by prolonged continuous infusionM J Ratain, N J Vogelzang
Pageof 23